| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing stem cell therapy in liver failure: Critical insights from meta-analysis
|
Wu, Jinyu
|
|
|
30 |
1 |
p.
|
artikel
|
| 2 |
A landscape of liver cirrhosis and transplantation in Mexico: Changing leading causes and transplant as response
|
Palma-Lara, Icela
|
|
|
30 |
1 |
p.
|
artikel
|
| 3 |
An exploratory machine learning model for predicting advanced liver fibrosis in autoimmune hepatitis patients: A preliminary study
|
Wei, Qinglin
|
|
|
30 |
1 |
p.
|
artikel
|
| 4 |
A social media listening study of patients’ experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study
|
Lazarus, Jeffrey V.
|
|
|
30 |
1 |
p.
|
artikel
|
| 5 |
Assessing liver fibrosis in chronic liver disease: Comparison of diffusion-weighted MR elastography and two-dimensional shear-wave elastography using histopathologic assessment as the reference standard
|
Yang, Li
|
|
|
30 |
1 |
p.
|
artikel
|
| 6 |
Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease
|
Kaya, Eda
|
|
|
30 |
1 |
p.
|
artikel
|
| 7 |
Brain reserve in hepatic encephalopathy: Pathways of damage and preventive strategies through lifestyle and therapeutic interventions
|
Cordova-Gallardo, Jacqueline
|
|
|
30 |
1 |
p.
|
artikel
|
| 8 |
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
|
Naully, Patricia Gita
|
|
|
30 |
1 |
p.
|
artikel
|
| 9 |
Challenges in the management of alcohol-associated liver disease in Latin America
|
Idalsoaga, Francisco
|
|
|
30 |
1 |
p.
|
artikel
|
| 10 |
Characterizing outcomes in a large cohort of latinx patients with autoimmune hepatitis
|
Belilos, Eleanor
|
|
|
30 |
1 |
p.
|
artikel
|
| 11 |
Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value
|
Zhang, Ying
|
|
|
30 |
1 |
p.
|
artikel
|
| 12 |
Clinical spectrum and long-term outcomes of non-cirrhotic portal venous system thrombosis in Hispanic population
|
Gil-López, Fernando
|
|
|
30 |
1 |
p.
|
artikel
|
| 13 |
Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation
|
Suzuki, Takanori
|
|
|
30 |
1 |
p.
|
artikel
|
| 14 |
Comment on “Development of machine learning-based personalized predictive models for risk evaluation of hepatocellular carcinoma in hepatitis B virus-related cirrhosis patients with low levels of serum alpha-fetoprotein”
|
Zhao, Liang
|
|
|
30 |
1 |
p.
|
artikel
|
| 15 |
Comment on “MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease”
|
Ma, Ying
|
|
|
30 |
1 |
p.
|
artikel
|
| 16 |
Development of a biodegradable prosthesis through tissue engineering, for the organ-replacement or substitution of the extrahepatic bile duct
|
Valderrama-Treviño, Alan Isaac
|
|
|
30 |
1 |
p.
|
artikel
|
| 17 |
Development of a biodegradable prosthesis through tissue engineering: the lack of the physiological abstractions prevents bioengineering innovations
|
Klabukov, Ilya
|
|
|
30 |
1 |
p.
|
artikel
|
| 18 |
Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
|
Sukaram, Thanikan
|
|
|
30 |
1 |
p.
|
artikel
|
| 19 |
Differentially expressed genes in Huh7 cells during co-culture with LX2 cells demonstrating dynamics of intercellular communication
|
Heredia-Torres, Tania G.
|
|
|
30 |
1 |
p.
|
artikel
|
| 20 |
Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases
|
Burra, Patrizia
|
|
|
30 |
1 |
p.
|
artikel
|
| 21 |
Editorial board
|
|
|
|
30 |
1 |
p.
|
artikel
|
| 22 |
Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD – a prospective interventional study
|
Vašura, Adam
|
|
|
30 |
1 |
p.
|
artikel
|
| 23 |
Efficacy of prophylactic antibiotics in the adjuvant treatment of alcohol-related liver disease (ALD): A systematic review and meta-analysisProphylactic antibiotics in ALD
|
Wang, Xiuyan
|
|
|
30 |
1 |
p.
|
artikel
|
| 24 |
EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway
|
Wang, Ling
|
|
|
30 |
1 |
p.
|
artikel
|
| 25 |
Energy metabolism: An emerging therapeutic frontier in liver fibrosis
|
Irshad, Iram
|
|
|
30 |
1 |
p.
|
artikel
|
| 26 |
Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study
|
Kochaksaraei, Golasa Samadi
|
|
|
30 |
1 |
p.
|
artikel
|
| 27 |
Erratum to “Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma” [Annals of Hepatology, Volume 27, (2022) 100678]
|
Zhu, Shuangmei
|
|
|
30 |
1 |
p.
|
artikel
|
| 28 |
Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease
|
Mittal, Ashi
|
|
|
30 |
1 |
p.
|
artikel
|
| 29 |
Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
|
Daza, Jimmy
|
|
|
30 |
1 |
p.
|
artikel
|
| 30 |
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
|
Romano, Jacob
|
|
|
30 |
1 |
p.
|
artikel
|
| 31 |
Exosomal linc00152 intensifies the crosstalk between cholangiocarcinoma cells and cancer-associated fibroblasts
|
Hu, Min
|
|
|
30 |
1 |
p.
|
artikel
|
| 32 |
Factors associated with obtaining lower IQR-CAP values in the detection of hepatic steatosis by transient elastography
|
López-Mendez, Iván
|
|
|
30 |
1 |
p.
|
artikel
|
| 33 |
FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
|
Álvares-da-Silva, Mário Reis
|
|
|
30 |
1 |
p.
|
artikel
|
| 34 |
Free fatty acid-induced DDX3 inhibits autophagy via miR-141 upregulation in diet-induced MASLD mice model system
|
Hossain, Md. Musa
|
|
|
30 |
1 |
p.
|
artikel
|
| 35 |
From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
|
Zhou, Mi
|
|
|
30 |
1 |
p.
|
artikel
|
| 36 |
Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis
|
Barreto, Camila Marques de Alcântara
|
|
|
30 |
1 |
p.
|
artikel
|
| 37 |
HLA-G liver expression in chronically HIV/hepatitis C-coinfected individuals.
|
Vilar, Fernando Crivelenti
|
|
|
30 |
1 |
p.
|
artikel
|
| 38 |
Impact of parenchymal transection techniques on intraoperative blood loss during liver resection in a porcine model of elevated central venous pressure: A comparative study
|
Kneifel, Felicia
|
|
|
30 |
1 |
p.
|
artikel
|
| 39 |
Integrated analyses and a novel nomogram for the prediction of significant fibrosis in patients
|
Lu, Mengxin
|
|
|
30 |
1 |
p.
|
artikel
|
| 40 |
Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region
|
Alqahtani, Saleh A.
|
|
|
30 |
1 |
p.
|
artikel
|
| 41 |
Letter to the editor—Opinion on article by Rodriguez-Alvarez F et al.
|
Rodríguez Villafuerte, Santiago
|
|
|
30 |
1 |
p.
|
artikel
|
| 42 |
Lipocalin-2 silencing alleviates sepsis-induced liver injury through inhibition of ferroptosis
|
Li, Yuping
|
|
|
30 |
1 |
p.
|
artikel
|
| 43 |
Liver stiffness measurement trajectory analysis for prognosis in patients with chronic hepatitis B and compensated advanced chronic liver disease
|
Jiang, Hao
|
|
|
30 |
1 |
p.
|
artikel
|
| 44 |
MCM3 promotes hepatocellular carcinoma progression via Epithelial-mesenchymal Transition through AKT/Twist signaling pathway
|
Tang, Wei-Guo
|
|
|
30 |
1 |
p.
|
artikel
|
| 45 |
Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
|
Mu, Chenyang
|
|
|
30 |
1 |
p.
|
artikel
|
| 46 |
Metabolic dysfunction and kidney disease risk in individuals with MAFLD
|
Pan, Ziyan
|
|
|
30 |
1 |
p.
|
artikel
|
| 47 |
Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
|
Xiao, Yiyuan
|
|
|
30 |
1 |
p.
|
artikel
|
| 48 |
One-stop shop endoscopy for patients with biliary pancreatitis: A Jack of all trades?
|
Krupa, Łukasz
|
|
|
30 |
1 |
p.
|
artikel
|
| 49 |
Outcomes and risk factors for de novo major depressive disorder after liver transplantation: Nested case-control study
|
Yoo, Young Jin
|
|
|
30 |
1 |
p.
|
artikel
|
| 50 |
PNPLA3 and SAMM50 variants are associated with lean nonalcoholic fatty liver disease in Asian population
|
Lu, Chia-Wen
|
|
|
30 |
1 |
p.
|
artikel
|
| 51 |
Predictive role of microvesicles in cirrhotic patients: A promised land or a land of confusion? A narrative review
|
Boccatonda, Andrea
|
|
|
30 |
1 |
p.
|
artikel
|
| 52 |
Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy
|
Franzè, Maria Stella
|
|
|
30 |
1 |
p.
|
artikel
|
| 53 |
Racial and ethnic disparities in alcohol-associated liver disease hospitalizations in Brazil before and after the COVID-19 pandemic
|
Heringer, Daniel L
|
|
|
30 |
1 |
p.
|
artikel
|
| 54 |
Racial differences in primary sclerosing cholangitis: A retrospective cohort study leveraging a new ICD-10 code
|
Wang, Melinda
|
|
|
30 |
1 |
p.
|
artikel
|
| 55 |
Response to letter to the editor by Rodriguez S et al.
|
Moctezuma-Velazquez, Carlos
|
|
|
30 |
1 |
p.
|
artikel
|
| 56 |
Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial
|
Song, Do Seon
|
|
|
30 |
1 |
p.
|
artikel
|
| 57 |
Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study
|
Wu, Qiaoling
|
|
|
30 |
1 |
p.
|
artikel
|
| 58 |
Soft drink consumption and increased risk of nonalcoholic fatty liver disease: Results from the health workers cohort study
|
Denova-Gutiérrez, Edgar
|
|
|
30 |
1 |
p.
|
artikel
|
| 59 |
The burden of hepatic encephalopathy and the use of albumin as a potential treatment
|
Bajaj, Jasmohan S.
|
|
|
30 |
1 |
p.
|
artikel
|
| 60 |
The dual role of HCV protein expression in communication between host cells presents potential applications in the treatment of liver fibrosis
|
Liu, Junxi
|
|
|
30 |
1 |
p.
|
artikel
|
| 61 |
The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
|
Fernández-Garibay, Valeria Michelle
|
|
|
30 |
1 |
p.
|
artikel
|
| 62 |
The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
|
Arrè, Valentina
|
|
|
30 |
1 |
p.
|
artikel
|
| 63 |
The Toulouse algorithm identifies patients with increased risk of cardiac decompensation only in patients with TIPS for refractory ascites
|
Vanderschueren, Emma
|
|
|
30 |
1 |
p.
|
artikel
|
| 64 |
Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1
|
Guo, Yinghao
|
|
|
30 |
1 |
p.
|
artikel
|
Tijdschrift beschrijving